Effectiveness of Selective Serotonin Reuptake Inhibitors Combined With Antipsychotic Medication for the Treatment of Psychotic Depression

Trial Profile

Effectiveness of Selective Serotonin Reuptake Inhibitors Combined With Antipsychotic Medication for the Treatment of Psychotic Depression

Completed
Phase of Trial: Phase III

Latest Information Update: 25 Apr 2017

At a glance

  • Drugs Sertraline (Primary) ; Olanzapine
  • Indications Major depressive disorder; Psychotic affective disorders
  • Focus Therapeutic Use
  • Acronyms STOP-PD
  • Most Recent Events

    • 25 Apr 2017 Results of association of baseline suicidality with study outcome (n=258) published in the Journal of Clinical Psychiatry
    • 01 Apr 2015 Results of secondary analysis have been published in the Journal of clinical psychiatry .
    • 01 Aug 2009 Results were published in the Archives of General Psychiatry.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top